IVUSAID is a free educational mobile application for medical professionals that provides case-based training on intravascular ultrasound (IVUS) for PCI guidance.
The App DNA
What makes this app unique?
The app removes the limitation of static textbook images by providing dynamic IVUS pullbacks and annotated cross-sections, helping clinicians bridge the gap between theory and procedural reality.
For Medical professionals, including interventional cardiology fellows, technicians, and early-career physicians.
What does it look like?
Key features
Fifty quizzes featuring annotated cross-sections and pullbacks to test clinical knowledge.
Twenty-one complex coronary cases demonstrating IVUS guidance for ACS, bifurcations, and calcified lesions.
Library of cross-sectional images and videos detailing plaque types, stent apposition, and artifacts.
How much does it cost?
The app is entirely free, serving as a professional educational tool to build brand authority for the Mount Sinai Heart institution.
Velocity
Maintenance developmentperformanceopaqueShow more...
The app currently operates at a maintenance cadence, with only one release shipped in the last 132 days. Development is limited to minor bug fixes and performance improvements, with no evidence of new features or live operations. The lack of substantive updates over the last four months suggests a focus on stability rather than active growth or content expansion.
Who built it?
Cardiology Apps
7 apps tracked · Medical
User Sentiment
What do users think recently?
The recent review mood reads excited. Users appreciate medical professionals find the educational content highly beneficial for learning to interpret complex imaging results and the initial content delivery is clear and accessible for users seeking professional medical guidance.
How are ratings & reviews evolving?
What users say, by theme
- Medical professionals find the educational content highly beneficial for learning to interpret complex imaging results
- The initial content delivery is clear and accessible for users seeking professional medical guidance
- Login failures and general app instability prevent users from accessing the educational content consistently
8 of 8 recent reviews analyzed · limited sample · Excited overall
Read the full review analysisUnlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for IVUSAID
How's the Medical market?
IVUSAID maintains a niche position in the medical education category with a 5-star rating on iOS. The lack of updates for over 130 days signals a maintenance-only posture that risks losing the professional audience to more frequently updated clinical reference tools.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for IVUSAID
Where is it heading?
The medical education app market is shifting toward high-frequency, cloud-synced reference tools that prioritize stability. IVUSAID's maintenance-only cadence leaves it exposed to technical obsolescence, and the current instability issues will likely lead to a decline in professional adoption if not addressed in the next release cycle.
- Persistent login failures and hardware instability in the latest release erode the professional user habit, which compounds the risk of long-term churn.
The SWOT
- Case-based library from Mount Sinai Heart establishes clinical authority
- Expanding interactive case library could increase professional engagement
Next best moves
Audit authentication flow because login failures are the top-cited barrier to content access → improve daily active usage
The counter-intuitive read
The app's maintenance-mode status is a strategic choice…
Read the full takeBottom line
IVUSAID provides high-value clinical content, but technical failures in the authentication flow currently block the user experience. Resolving these stability issues is the necessary move to protect the brand authority established by the Mount Sinai Heart institution.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
Report last updated